Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01597908
Brief Title: Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma (COMBI-v)

First Submitted : May 10, 2012
First Submitted that Met QC Criteria : May 10, 2012
First Posted : May 14, 2012 (Estimate)

Results First Submitted : December 1, 2014
Results First Submitted that Met QC Criteria : December 1, 2014
Results First Posted : December 4, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : February 8, 2021
Last Update Posted : February 24, 2021